Genzyme Genetics Goes for $925M in Deal with LabCorp

Genzyme Corp. landed a better-than-expected deal for its genetic testing business, selling Genzyme Genetics to Laboratory Corp. of America for $925 million in cash and increasing the odds that Sanofi-Aventis SA could raise its acquisition bid. (BioWorld Today)